000 02021 a2200589 4500
005 20250516094057.0
264 0 _c20121010
008 201210s 0 0 eng d
022 _a1872-7980
024 7 _a10.1016/j.canlet.2012.05.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYuan, Qianying
245 0 0 _aA new protoapigenone analog RY10-4 induces apoptosis and suppresses invasion through the PI3K/Akt pathway in human breast cancer.
_h[electronic resource]
260 _bCancer letters
_cNov 2012
300 _a210-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBlotting, Western
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Movement
_xdrug effects
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Nude
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aPhosphatidylinositol 3-Kinase
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-akt
_xmetabolism
650 0 4 _aPyrones
_xpharmacology
650 0 4 _aS Phase Cell Cycle Checkpoints
_xdrug effects
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTime Factors
650 0 4 _aTumor Burden
_xdrug effects
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aCai, Shaoxin
700 1 _aZhang, Xuenong
700 1 _aLiu, Ziwei
700 1 _aLi, Zhaoming
700 1 _aLuo, Xuelai
700 1 _aXiong, Chaomei
700 1 _aWang, Jianping
700 1 _aHu, Junbo
700 1 _aRuan, Jinlan
773 0 _tCancer letters
_gvol. 324
_gno. 2
_gp. 210-20
856 4 0 _uhttps://doi.org/10.1016/j.canlet.2012.05.025
_zAvailable from publisher's website
999 _c21826017
_d21826017